Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8782
+0.0135 (1.56%)
Oct 8, 2025, 1:47 PM EDT
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $3.82 million as of October 8, 2025. Its market cap has decreased by -37.78% in one year.
Market Cap
3.82M
Enterprise Value
6.47M
Revenue
45.45M
Ranking
n/a
PE Ratio
5.61
Stock Price
$0.88
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 3.82M, a decrease of -98.28%. That is a compound annual growth rate of -13.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 3.82M | -67.80% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | 12.69M | -33.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 528.17M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 277.90M |
| Silence Therapeutics | 242.78M |